Spectranetics (Nasdaq: SPNC) reported earnings on Feb. 21. Here are the numbers you need to know.

The 10-second takeaway
 For the quarter ended Dec. 31 (Q4), Spectranetics beat expectations on revenues and met expectations on earnings per share.

Compared to the prior-year quarter, revenue expanded. Non-GAAP earnings per share contracted. GAAP earnings per share grew.

Gross margins increased, operating margins dropped, net margins grew.

Revenue details
 Spectranetics reported revenue of $36.8 million. The six analysts polled by S&P Capital IQ wanted to see revenue of $35.6 million on the same basis. GAAP reported sales were 13% higher than the prior-year quarter's $32.5 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 EPS came in at $0.03. The six earnings estimates compiled by S&P Capital IQ predicted $0.03 per share. Non-GAAP EPS of $0.03 for Q4 were 25% lower than the prior-year quarter's $0.04 per share. GAAP EPS of $0.02 for Q4 were 100% higher than the prior-year quarter's $0.01 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
 For the quarter, gross margin was 73.3%, 40 basis points better than the prior-year quarter. Operating margin was 3.4%, 230 basis points worse than the prior-year quarter. Net margin was 1.8%, 70 basis points better than the prior-year quarter.

Looking ahead
 Next quarter's average estimate for revenue is $36.5 million. On the bottom line, the average EPS estimate is -$0.04.

Next year's average estimate for revenue is $153.0 million. The average EPS estimate is $0.00.

Investor sentiment
 The stock has a one-star rating (out of five) at Motley Fool CAPS, with 153 members out of 172 rating the stock outperform, and 19 members rating it underperform. Among 40 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 33 give Spectranetics a green thumbs-up, and seven give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Spectranetics is outperform, with an average price target of $15.93.

Looking for alternatives to Spectranetics? It takes more than great companies to build a fortune for the future. Learn the basic financial habits of millionaires next door and get focused stock ideas in our free report, "3 Stocks That Will Help You Retire Rich." Click here for instant access to this free report.